Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment
Recruiting · NCT01205815 · Observational (researchers observe without assigning treatment) · Lead sponsor: Vanderbilt-Ingram Cancer Center
View the official record on ClinicalTrials.gov →Interventions studied
Tissue and blood collection
What this trial is about
The purpose of this research is to identify biological characteristics occurring in the initiation and progression of melanoma.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Pathologically-proven diagnosis of melanoma.
- Patient must have a test or procedure that has the potential to provide left-over tissue that can be banked for future research purposes OR the patient has already had a diagnostic or therapeutic procedure but who has not yet been approached to participate is also eligible.
Exclusion criteria
- Any patient with significant contraindications to venipuncture (e.g., severe anemia) will be excluded from blood collection procedures. However, if the patient provides consent and a paraffin-embedded block or 10-15 unstained slides of their tissue diagnosis, they will not be excluded from this protocol.
- Any patient unable or unwilling to provide consent.
Where it is running
1 location listed across 1 US state.
- Vanderbitl-Ingram Cancer Center - Nashville, Tennessee, United States